19-8-2013 — /EuropaWire/ — Company Highlights April - June 2013 Biotie obtained an exclusive option to acquire Neurelis, Inc., a private specialty…
Turku, 30-5-2013 — /europawire.eu/ — Biotie today announced that its partner H.Lundbeck A/S (Lundbeck) has launched Selincro in the United Kingdom.…
Turku, 29-5-2013 — /europawire.eu/ — Biotie Therapies today announced the start of a Phase 2 clinical study evaluating nepicastat (SYN117) in…